Results 141 to 150 of about 393,600 (259)

Cerebral perfusion in invasive meningococcal disease [PDF]

BMJ, 2008
I am surprised that the SIGN guidelines (and therefore this summary of them1) make no mention of the importance of adequate cerebral perfusion in those with invasive meningococcal disease. Cerebral perfusion pressure is the difference between the mean arterial pressure (which is usually low from the associated hypotensive shock) and …
openaire   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

Transplant Infectious Disease, Volume 28, Issue 1, January/February 2026.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden, David Reynoso, Reema Mathew, Michael Loeffelholz   +3 more
wiley   +1 more source

Vaccine implementation: Alaska 2017 [PDF]

, 2017
Bacterial meningitis is a serious disease that causes permanent dysfunction or death; adolescents and young adults carry the greatest risk. The national Advisory Committee on Immunization Practices (ACIP) has released vaccine recommendations that include
Hulstine, Amanda
core  

Dam inactivation in : prevalence among diverse hyperinvasive lineages [PDF]

, 2004
Background DNA adenine methyltransferase (Dam) activity is absent in many, but not all, disease isolates of Neisseria meningitidis, as a consequence of the insertion of a restriction endonuclease-encoding gene, the 'dam replacing gene' (drg) at the dam ...
Moxon E Richard, Sun Li, Jolley Keith A, Maiden Martin CJ   +3 more
core   +2 more sources

Invasive meningococcal disease: timing and cause of death in England, 2008-2015.

Journal of Infection, 2020
BACKGROUND Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia, with death often occurring rapidly after onset of the first symptoms.
Kazim Beebeejaun, S. Parikh, H. Campbell, S. Gray, R. Borrow, M. Ramsay, S. Ladhani   +6 more
semanticscholar   +1 more source

Fragment Templates in Molecularly Imprinted Polymer Synthesis: Design Strategies, Critical Factors, and Analytical Applications

Advances in Materials Science and Engineering, Volume 2026, Issue 1, 2026.
The utilization of fragment templates in molecular imprinting polymer (MIP) synthesis attracts significant interest in its potential to create polymers with high specificity in recognizing target molecules. The primary advantage of fragment templates lies in their capacity to extract target molecules by focusing on specific components, thus forming ...
Ezra Calista Hutapea, Diva Dhaifina Mazaya Priana, Driyanti Rahayu, Aliya Nur Hasanah, Mohammad Rezwan Habib   +4 more
wiley   +1 more source

Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex.

Journal of Infection, 2020
INTRODUCTION Invasive meningococcal disease (IMD) caused by non-serogroupable (NG) strains mainly affects immunocompromised individuals. Reduced susceptibility to penicillin in meningococci is increasing in Europe but ciprofloxacin resistance remains ...
Laura Willerton, J. Lucidarme, H. Campbell, D. Caugant, H. Claus, S. Jacobsson, S. Ladhani, P. Mölling, A. Neri, P. Stefanelli, M. Taha, U. Vogel, R. Borrow   +12 more
semanticscholar   +1 more source

Autosplenectomy in a Patient With Autoimmune Polyglandular Syndrome Type 2 (APS‐2)

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Autoimmune glandular syndrome type 2 is a complex genetic condition where a triad of endocrinopathies is involved, namely, Addison’s disease, type 1 diabetes, and/or autoimmune thyroid disorder. The disease predisposes one to a variety of other autoimmune associations.
Luqman S. Fauzi, Airin Jyoty, Yashwin Sredharan, Manohara Kenchaiah, Osamu Isozaki   +4 more
wiley   +1 more source

Genome-based study of a spatio-temporal cluster of invasive meningococcal disease due to Neisseria meningitidis serogroup C, clonal complex 11 [PDF]

, 1925
SummaryObjectivesTo describe a spatio-temporal cluster of invasive meningococcal disease (IMD) due to serogroup C meningococci, occurred in a restricted area of Tuscany between January and October 2015, and the results of whole genome sequencing (WGS ...
P. Stefanelli, C. Fazio, A. Neri, A. Ciammaruconi, E. Balocchini, A. Anselmo, C. Azzari, G.M. Rossolini, P. Vacca, A. Fortunato, A. Palozzi, S. Fillo, F. Lista, M. Moriondo, F. Nieddu, G. Rezza, Stefanelli, Miller, Cano, de Greeff, Hellebrand, Ministero della Salute, Aubert, Marcus, Zhu, Andrews, Joshi, Simpson, Huson, Gardner, Felsenstein, Stecher, Elias, Stefanelli, Stefanelli, Fazio, Tzeng, Ladhani, Trotter, Ramsay, Trotter, Trotter, Maiden, Hill, Lucidarme, Sáfadi   +45 more
core   +8 more sources

Evaluating the Real‐World Safety of Ravulizumab in Generalized Myasthenia Gravis: Insights From a Detailed Analysis of FAERS Data

Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Background Ravulizumab represents the inaugural long‐acting complement C5 inhibitor that has received approval in various countries around the globe for individuals diagnosed with generalized myasthenia gravis (gMG) who are positive for anti‐acetylcholine receptor antibodies.
Yakun Wang, Qian Guo, Jiayu Bai, Jiaqi Shi, Ziquan Yang, Hongda Liu   +5 more
wiley   +1 more source